Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) ▼ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Knight Therapeutics | 1 | 0 | 0 | 0 | €4.08 | €10.00 | 145.098% |
| VBI Vaccines Inc. | 1 | 0 | 0 | 0 | €0.59 | €3.00 | 408.475% |
| Adverum Biotechnologies Inc. | 7 | 0 | 3 | 0 | €1.38 | €5.60 | 305.913% |
| Uniqure B.V. | 1 | 0 | 1 | 0 | €4.61 | - | - |
| Poxel S.A. | 1 | 0 | 0 | 0 | €0.58 | €0.70 | 21.739% |
| Biolife Solutions Inc | 2 | 0 | 2 | 0 | €20.00 | €32.00 | 60.000% |
| Axsome Therapeutics Inc | 2 | 0 | 0 | 0 | €70.44 | €100.00 | 41.965% |
| Purple Biotech Ltd. ADR | 5 | 0 | 1 | 0 | €0.51 | €9.21 | 1705.294% |
| Rhythm Pharmaceuticals | 15 | 0 | 2 | 0 | €35.00 | €45.98 | 31.371% |
| Nektar Therapeutics | 3 | 1 | 0 | 0 | €1.62 | €3.70 | 129.102% |
| Merck & Co. Inc. | 28 | 1 | 1 | 0 | €120.80 | €124.93 | 3.418% |
| Catalyst Pharmaceutical Partners Inc | 11 | 0 | 1 | 0 | €15.18 | €24.13 | 58.980% |
| Novo Nordisk A/S | 5 | 0 | 1 | 0 | €185.00 | €170.00 | -8.108% |
| Trinity Biotech ADR | 23 | 0 | 1 | 0 | €0.41 | - | - |
| Immutep LTD ADR | 1 | 0 | 0 | 0 | €2.60 | €4.00 | 53.846% |
| Verastem Inc. | 10 | 0 | 1 | 0 | €10.60 | €24.63 | 132.404% |
| Xeris Biopharma Holdings Inc. | 5 | 0 | 1 | 0 | €1.82 | €4.16 | 129.015% |
| Abbott Laboratories | 16 | 0 | 2 | 0 | €95.75 | €116.81 | 21.992% |
| UCB S.A. | 2 | 0 | 0 | 0 | €124.85 | - | - |
| Perrigo Co. plc | 3 | 0 | 0 | 0 | €27.44 | €35.99 | 31.142% |
| Vertex Pharmaceuticals Inc. | 45 | 2 | 6 | 0 | €409.55 | €409.07 | -0.118% |
| Dynavax Technologies Corp | 2 | 0 | 1 | 0 | €10.23 | €26.95 | 163.567% |
| GSK plc | 1 | 0 | 0 | 0 | €20.61 | - | - |
| Grifols S.A. | 1 | 0 | 0 | 0 | €10.10 | - | - |
| Cytokinetics Inc. | 27 | 1 | 4 | 0 | €55.00 | €85.64 | 55.715% |